Effects of streptococcus pneumoniae strain background on complement resistance

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Hyams, Catherine ^a   Opel, Sophia ^a   Hanage, William ^b   Yuste, Jose ^c   Bax, Katie ^d   Henriques Normark, Birgitta ^e   Spratt, Brian G ^f   Brown, Jeremy S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^f ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN G; BACTERIUM ANTIBODY; COMPLEMENT COMPONENT C1Q;

ARTICLE; BACTERIAL GENETICS; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME BINDING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; NEUTROPHIL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; BACTERIAL MEMBRANE; CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROTEIN BINDING; SEROTYPING;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; COMPLEMENT C1Q; COMPLEMENT SYSTEM PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; NEUTROPHILS; PROTEIN BINDING; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 80054744801     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024581     Document Type: Article

References (49)

1. Jonsson G, Truedsson L, Sturfelt G, Oxelius VA, Braconier JH, et al. (2005) Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore) 84: 23-34.
2. Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, et al. (2002) The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. PNAS USA 99: 16969-16974.
3. Xu Y, Ma M, Ippolito GC, Schroeder HW Jr, Carroll MC, et al. (2001) Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A 98: 14577-14582.
4. Kerr AR, Paterson GK, Riboldi-Tunnicliffe A, Mitchell TJ, (2005) Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3. Infect Immun 73: 4245-4252.
5. Walport MJ, (2001) Complement- Second of Two Parts. The New England Journal of Medicine 344: 1140-1144.
6. Briles DE, Nahm M, Schroer K, Davie J, Baker P, et al. (1981) Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 153: 694-705.
7. Yuste J, Botto M, Bottoms SE, Brown JS, (2007) Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog 3: 1208-1219.
8. Kang YS, Do Y, Lee HK, Park SH, Cheong C, et al. (2006) A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 125: 47-58.
9. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, et al. (2000) Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68: 688-693.
10. Yuste J, Sen A, Truedsson L, Jonsson G, Tay LS, et al. (2008) Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect Immun 76: 3761-3770.
11. Haas KM, Hasegawa M, Steeber DA, Poe JC, Zabel MD, et al. (2002) Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17: 713-723.
12. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS, (2010) The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun 78: 704-715.
13. Yuste J, Botto M, Paton JC, Holden DW, Brown JS, (2005) Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia. J Immunol 175: 1813-1819.
14. Yuste J, Khandavilli S, Ansari N, Muttardi K, Ismail L, et al. (2010) The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype. Infect Immun 78: 283-292.
15. Dalia AB, Standish AJ, Weiser JN, (2010) Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils. Infect Immun 78: 2108-2116.
16. Ogunniyi AD, Grabowicz M, Mahdi LK, Cook J, Gordon DL, et al. (2009) Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. Faseb J 23: 731-738.
17. Tu AH, Fulgham RL, McCrory MA, Briles DE, Szalai AJ, (1999) Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect Immun 67: 4720-4724.
18. Dieudonne-Vatran A, Krentz S, Blom AM, Meri S, Henriques-Normark B, et al. (2009) Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J Immunol 182: 7865-7877.
19. Ren B, McCrory MA, Pass C, Bullard DC, Ballantyne CM, et al. (2004) The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection. J Immunol 173: 7506-7512.
20. Melin M, Di Paolo E, Tikkanen L, Jarva H, Neyt C, et al. (2010) Interaction of pneumococcal histidine triad proteins with human complement. Infect Immun 78: 2089-2098.
21. Angel CS, Ruzek M, Hostetter MK, (1994) Degradation of C3 by Streptococcus pneumoniae. J Infect Dis 170: 600-608.
22. Hostetter MK, (1986) Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis 153: 682-693.
23. Melin M, Jarva H, Siira L, Meri S, Kayhty H, et al. (2009) Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun 77: 676-684.
24. Abeyta M, Hardy GG, Yother J, (2003) Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun 71: 218-225.
25. Melin M, Trzcinski K, Meri S, Kayhty H, Vakevainen M, (2010) The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect Immun 78: 5262-5270.
26. Hyams C, Yuste J, Bax K, Camberlein E, Weiser JN, et al. (2010) Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on capsular serotype. Infect Immun 78: 716-725.
27. Hakenbeck R, Balmelle N, Weber B, Gardes C, Keck W, et al. (2001) Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae. Infect Immun 69: 2477-2486.
28. Hiller NL, Janto B, Hogg JS, Boissy R, Yu S, et al. (2007) Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenome. J Bacteriol 189: 8186-8195.
29. Hollingshead SK, Becker R, Briles DE, (2000) Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 68: 5889-5900.
30. Iannelli F, Oggioni MR, Pozzi G, (2002) Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene 284: 63-71.
31. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, et al. (2001) Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293: 498-506.
32. Embry A, Hinojosa E, Orihuela CJ, (2007) Regions of Diversity 8, 9 and 13 contribute to Streptococcus pneumoniae virulence. BMC Microbiol 7: 80.
33. Dagerhamn J, Blomberg C, Browall S, Sjostrom K, Morfeldt E, et al. (2008) Determination of accessory gene patterns predicts the same relatedness among strains of Streptococcus pneumoniae as sequencing of housekeeping genes does and represents a novel approach in molecular epidemiology. J Clin Microbiol 46: 863-868.
34. Sabharwal V, Ram S, Figueira M, Park IH, Pelton SI, (2009) Role of complement in host defense against pneumococcal otitis media. Infect Immun 77: 1121-1127.
35. Melin M, Trzcinski K, Antonio M, Meri S, Adegbola R, et al. (2010) Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae. Infect Immun 78: 5252-5261.
36. Enright MC, Spratt BG, (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144: 3049-3060.
37. Kim JO, Weiser JN, (1998) Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 177: 368-377.
38. von Pawel-Rammingen U, Johansson BP, Bjorck L, (2002) IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 21: 1607-1615.
39. Yuste J, Ali S, Sriskandan S, Hyams C, Botto M, et al. (2006) Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes. J Immunol 176: 6112-6120.
40. Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, et al. (2006) Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 194: 682-688.
41. Weinberger DM, Trzcinski K, Lu YJ, Bogaert D, Brandes A, et al. (2009) Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 5: e1000476.
42. Sandgren A, Sjostrom K, Olsson-Liljequist B, Christensson B, Samuelsson A, et al. (2004) Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 189: 785-796.
43. Dave S, Pangburn MK, Pruitt C, McDaniel LS, (2004) Interaction of human factor H with PspC of Streptococcus pneumoniae. Indian J Med Res 119 (Suppl): 66-73.
44. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187: 1424-1432.
45. Hanage WP, Kaijalainen TH, Syrjanen RK, Auranen K, Leinonen M, et al. (2005) Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun 73: 431-435.
46. Weiser JN, (1998) Phase variation in colony opacity by Streptococcus pneumoniae. Microb Drug Resist 4: 129-135.
47. Segal AW, Jones OT, (1980) Absence of cytochrome b reduction in stimulated neutrophils from both female and male patients with chronic granulomatous disease. FEBS Lett 110: 111-114.
48. Hammerschmidt S, Wolff S, Hocke A, Rosseau S, Müller E, et al. (2005) Ilustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun 73: 4653-4667.
49. Weinberger DM, Trzciński K, Lu YJ, Bogaert D, Brandes A, et al. (2009) Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 25: e1000476.